Cargando…
Evaluation of the performance of algorithms mapping EORTC QLQ-C30 onto the EQ-5D index in a metastatic colorectal cancer cost-effectiveness model
BACKGROUND: Cost-effectiveness models require quality of life utilities calculated from generic preference-based questionnaires, such as EQ-5D. We evaluated the performance of available algorithms for QLQ-C30 conversion into EQ-5D-3L based utilities in a metastatic colorectal cancer (mCRC) patient p...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7370458/ https://www.ncbi.nlm.nih.gov/pubmed/32690011 http://dx.doi.org/10.1186/s12955-020-01481-2 |
_version_ | 1783560981280980992 |
---|---|
author | Franken, Mira D. de Hond, Anne Degeling, Koen Punt, Cornelis J. A. Koopman, Miriam Uyl-de Groot, Carin A. Versteegh, Matthijs M. van Oijen, Martijn G. H. |
author_facet | Franken, Mira D. de Hond, Anne Degeling, Koen Punt, Cornelis J. A. Koopman, Miriam Uyl-de Groot, Carin A. Versteegh, Matthijs M. van Oijen, Martijn G. H. |
author_sort | Franken, Mira D. |
collection | PubMed |
description | BACKGROUND: Cost-effectiveness models require quality of life utilities calculated from generic preference-based questionnaires, such as EQ-5D. We evaluated the performance of available algorithms for QLQ-C30 conversion into EQ-5D-3L based utilities in a metastatic colorectal cancer (mCRC) patient population and subsequently developed a mCRC specific algorithm. Influence of mapping on cost-effectiveness was evaluated. METHODS: Three available algorithms were compared with observed utilities from the CAIRO3 study. Six models were developed using 5-fold cross-validation: predicting EQ-5D-3L tariffs from QLQ-C30 functional scale scores, continuous QLQ-C30 scores or dummy levels with a random effects model (RE), a most likely probability method on EQ-5D-3L functional scale scores, a beta regression model on QLQ-C30 functional scale scores and a separate equations subgroup approach on QLQ-C30 functional scale scores. Performance was assessed, and algorithms were tested on incomplete QLQ-C30 questionnaires. Influence of utility mapping on incremental cost/QALY gained (ICER) was evaluated in an existing Dutch mCRC cost-effectiveness model. RESULTS: The available algorithms yielded mean utilities of 1: 0.87 ± sd:0.14,2: 0.81 ± 0.15 (both Dutch tariff) and 3: 0.81 ± sd:0.19. Algorithm 1 and 3 were significantly different from the mean observed utility (0.83 ± 0.17 with Dutch tariff, 0.80 ± 0.20 with U.K. tariff). All new models yielded predicted utilities drawing close to observed utilities; differences were not statistically significant. The existing algorithms resulted in an ICER difference of €10,140 less and €1765 more compared to the observed EQ-5D-3L based ICER (€168,048). The preferred newly developed algorithm was €5094 higher than the observed EQ-5D-3L based ICER. Disparity was explained by minimal diffences in incremental QALYs between models. CONCLUSION: Available mapping algorithms sufficiently accurately predict utilities. With the commonly used statistical methods, we did not succeed in developping an improved mapping algorithm. Importantly, cost-effectiveness outcomes in this study were comparable to the original model outcomes between different mapping algorithms. Therefore, mapping can be an adequate solution for cost-effectiveness studies using either a previously designed and validated algorithm or an algorithm developed in this study. |
format | Online Article Text |
id | pubmed-7370458 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-73704582020-07-21 Evaluation of the performance of algorithms mapping EORTC QLQ-C30 onto the EQ-5D index in a metastatic colorectal cancer cost-effectiveness model Franken, Mira D. de Hond, Anne Degeling, Koen Punt, Cornelis J. A. Koopman, Miriam Uyl-de Groot, Carin A. Versteegh, Matthijs M. van Oijen, Martijn G. H. Health Qual Life Outcomes Research BACKGROUND: Cost-effectiveness models require quality of life utilities calculated from generic preference-based questionnaires, such as EQ-5D. We evaluated the performance of available algorithms for QLQ-C30 conversion into EQ-5D-3L based utilities in a metastatic colorectal cancer (mCRC) patient population and subsequently developed a mCRC specific algorithm. Influence of mapping on cost-effectiveness was evaluated. METHODS: Three available algorithms were compared with observed utilities from the CAIRO3 study. Six models were developed using 5-fold cross-validation: predicting EQ-5D-3L tariffs from QLQ-C30 functional scale scores, continuous QLQ-C30 scores or dummy levels with a random effects model (RE), a most likely probability method on EQ-5D-3L functional scale scores, a beta regression model on QLQ-C30 functional scale scores and a separate equations subgroup approach on QLQ-C30 functional scale scores. Performance was assessed, and algorithms were tested on incomplete QLQ-C30 questionnaires. Influence of utility mapping on incremental cost/QALY gained (ICER) was evaluated in an existing Dutch mCRC cost-effectiveness model. RESULTS: The available algorithms yielded mean utilities of 1: 0.87 ± sd:0.14,2: 0.81 ± 0.15 (both Dutch tariff) and 3: 0.81 ± sd:0.19. Algorithm 1 and 3 were significantly different from the mean observed utility (0.83 ± 0.17 with Dutch tariff, 0.80 ± 0.20 with U.K. tariff). All new models yielded predicted utilities drawing close to observed utilities; differences were not statistically significant. The existing algorithms resulted in an ICER difference of €10,140 less and €1765 more compared to the observed EQ-5D-3L based ICER (€168,048). The preferred newly developed algorithm was €5094 higher than the observed EQ-5D-3L based ICER. Disparity was explained by minimal diffences in incremental QALYs between models. CONCLUSION: Available mapping algorithms sufficiently accurately predict utilities. With the commonly used statistical methods, we did not succeed in developping an improved mapping algorithm. Importantly, cost-effectiveness outcomes in this study were comparable to the original model outcomes between different mapping algorithms. Therefore, mapping can be an adequate solution for cost-effectiveness studies using either a previously designed and validated algorithm or an algorithm developed in this study. BioMed Central 2020-07-20 /pmc/articles/PMC7370458/ /pubmed/32690011 http://dx.doi.org/10.1186/s12955-020-01481-2 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Franken, Mira D. de Hond, Anne Degeling, Koen Punt, Cornelis J. A. Koopman, Miriam Uyl-de Groot, Carin A. Versteegh, Matthijs M. van Oijen, Martijn G. H. Evaluation of the performance of algorithms mapping EORTC QLQ-C30 onto the EQ-5D index in a metastatic colorectal cancer cost-effectiveness model |
title | Evaluation of the performance of algorithms mapping EORTC QLQ-C30 onto the EQ-5D index in a metastatic colorectal cancer cost-effectiveness model |
title_full | Evaluation of the performance of algorithms mapping EORTC QLQ-C30 onto the EQ-5D index in a metastatic colorectal cancer cost-effectiveness model |
title_fullStr | Evaluation of the performance of algorithms mapping EORTC QLQ-C30 onto the EQ-5D index in a metastatic colorectal cancer cost-effectiveness model |
title_full_unstemmed | Evaluation of the performance of algorithms mapping EORTC QLQ-C30 onto the EQ-5D index in a metastatic colorectal cancer cost-effectiveness model |
title_short | Evaluation of the performance of algorithms mapping EORTC QLQ-C30 onto the EQ-5D index in a metastatic colorectal cancer cost-effectiveness model |
title_sort | evaluation of the performance of algorithms mapping eortc qlq-c30 onto the eq-5d index in a metastatic colorectal cancer cost-effectiveness model |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7370458/ https://www.ncbi.nlm.nih.gov/pubmed/32690011 http://dx.doi.org/10.1186/s12955-020-01481-2 |
work_keys_str_mv | AT frankenmirad evaluationoftheperformanceofalgorithmsmappingeortcqlqc30ontotheeq5dindexinametastaticcolorectalcancercosteffectivenessmodel AT dehondanne evaluationoftheperformanceofalgorithmsmappingeortcqlqc30ontotheeq5dindexinametastaticcolorectalcancercosteffectivenessmodel AT degelingkoen evaluationoftheperformanceofalgorithmsmappingeortcqlqc30ontotheeq5dindexinametastaticcolorectalcancercosteffectivenessmodel AT puntcornelisja evaluationoftheperformanceofalgorithmsmappingeortcqlqc30ontotheeq5dindexinametastaticcolorectalcancercosteffectivenessmodel AT koopmanmiriam evaluationoftheperformanceofalgorithmsmappingeortcqlqc30ontotheeq5dindexinametastaticcolorectalcancercosteffectivenessmodel AT uyldegrootcarina evaluationoftheperformanceofalgorithmsmappingeortcqlqc30ontotheeq5dindexinametastaticcolorectalcancercosteffectivenessmodel AT versteeghmatthijsm evaluationoftheperformanceofalgorithmsmappingeortcqlqc30ontotheeq5dindexinametastaticcolorectalcancercosteffectivenessmodel AT vanoijenmartijngh evaluationoftheperformanceofalgorithmsmappingeortcqlqc30ontotheeq5dindexinametastaticcolorectalcancercosteffectivenessmodel |